Association of a recombinational repair protein RAD51 with tumor suppressors BRCA1 and BRCA2 suggests that defects in homologous recombination are responsible for tumor formation. Also recent ®ndings that a protein associated with the MRE11/RAD50 repair complex is mutated in Nijmegen breakage syndrome characterized by increased cancer incidence and ionizing radiation sensitivity strongly support this idea. However, the direct roles of BRCA proteins and the protein responsible for NBS in recombinational repair are not clear though they are associated with the recombinational repair complexes. Since RAD51 forms a complex with other members of the RAD52 epistasis group and with BRCA proteins, it is reasonable to ask if alterations of members of the RAD52 epistasis group lead to tumor development. Here we describe missense mutations at functional regions of RAD54 and the absence of the wild-type RAD54 expression resulting from aberrant splicing in primary cancers. Since RAD54 is a recombinational protein associated with RAD51, this is the ®rst genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.
Association of a recombinational repair protein RAD51 with tumor suppressors BRCA1 and BRCA2 suggests that defects in homologous recombination are responsible for tumor formation. Also recent ®ndings that a protein associated with the MRE11/RAD50 repair complex is mutated in Nijmegen breakage syndrome characterized by increased cancer incidence and ionizing radiation sensitivity strongly support this idea. However, the direct roles of BRCA proteins and the protein responsible for NBS in recombinational repair are not clear though they are associated with the recombinational repair complexes. Since RAD51 forms a complex with other members of the RAD52 epistasis group and with BRCA proteins, it is reasonable to ask if alterations of members of the RAD52 epistasis group lead to tumor development. Here we describe missense mutations at functional regions of RAD54 and the absence of the wild-type RAD54 expression resulting from aberrant splicing in primary cancers. Since RAD54 is a recombinational protein associated with RAD51, this is the ®rst genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.
Keywords: RAD54; cancer; mutation In yeast, double-strand break (DSB) repair occurs through a pathway of homologous recombination that involves the RAD52 epistasis group proteins. The structural and functional conservation of RAD51, RAD52 and RAD54 throughout evolution supports the idea that the recombinational repair pathway is retained in mammals (Essers et al., 1997; Bezzubova et al., 1997) . RAD51 is associated with BRCA1 and BRCA2 tumor suppressor gene products, suggesting that a defect in recombination leads to tumor development (Scully et al., 1997; Sharan et al., 1997) . Further evidence for this came from the identi®cation of NBS1, responsible for Nijmegen breakage syndrome with increased cancer incidence, from the MRE11/ RAD50 recombination complex (Varon et al., 1998; Carney et al., 1998; Matsuura et al., 1998) . It is, therefore, probable that members of the RAD52 epistasis group are altered in cancer.
To investigate whether RAD54, a member of the RAD52 epistasis group, is mutated in human cancer, we performed SSCP analysis and direct sequencing of PCR products using mRNAs from 132 unselected primary tumors including 95 breast cancers, 13 colorectal cancers and 24 lymphomas. SSCP analysis exhibited two mutations ( Figure 1a) . Direct sequencing revealed a mutation, which did not show shifted bands of SSCP (Figure 1b) . Histological analysis of a breast tumor Br7 (from a 63-year-old female patient with no obvious family history of cancer) showed an invasive ductal carcinoma. A G to A transition converted Gly to Arg at codon 325 within helicase motif III. The absence of the wild-type allele indicates that Br7 was homozygous for the mutation. The corresponding normal tissue shows the same transition, indicating that this is a germline mutation. As we could not detect this mutation by SSCP analysis, a restriction-based screen was performed. The mutation in Br7 abolishes an AccIII site, preventing the digestion of a PCR fragment. This assay revealed that this mutation was absent in 100 normal individuals (200 chromosomes).
A tumor KCo11 was derived from an adenocarcinoma of the colon. A C to A transversion converted Pro to His at codon 63 upstream of helicase domains ( Figure 1c) . The corresponding normal tissue shows the wild-type sequence, indicating that this is a somatic mutation. A tumor Ly18 was derived from a nonHodgkin's lymphoma. A T to A transversion converted Val to Glu at codon 444 between helicase domains III and IV (Figure 1d ). Since we could not obtain the corresponding normal tissue, we do not know whether this is a germline mutation. The presence of the wildtype alleles indicates that these tumors were heterozygous for the mutations. To exclude the possibility that base transitions in KCo11 and Ly18 represent polymorphisms, we examined mRNAs from 100 normal individuals (200 chromosomes) by SSCP analysis and con®rmed that these transversions are absent in controls. Heterozygous mutations may be responsible for tumor formation if they act in a dominant-negative manner. In addition to these mutations (Table 1) , a number of polymorphisms were identi®ed (Table 2) .
Based on sequence homology (Eisen et al., 1995) , RAD54 belongs to the SNF2/SWI2 superfamily of DNA and RNA helicases whose members play roles in genome integrity including transcriptional regulation (SNF2, MOT and BRM), chromosome stability (lodestar), nucleotide excision repair (ERCC6 and RAD16) and recombination (RAD54). Although helicase activities of members of the SNF2/SWI2 superfamily remain to be demonstrated, conservation of the helicase motifs throughout evolution strongly suggests their functional importance. Therefore, mutations that cause amino acid substitutions at helicase motifs can lead to their altered function. Seven helicase motifs characteristic of the SNF2/SWI2 superfamily are present in RAD54 (Kanaar et al., 1996; Rasio et al., 1997) . Gly at codon 325, which was mutated in Br7, is at a conserved position in helicase motifs from yeast to human in members of the SNF2/SWI2 superfamily regardless of species and subfamily ( Figure 2a ). It is, therefore, highly likely that this mutation aects the function of RAD54 mediated by the helicase motif.
Although Pro at codon 63 and Val at codon 444 are outside helicase motifs, it is likely that these amino acid substitutions aect the function of RAD54. The interaction between RAD54 and RAD51 is mediated by the protein containing the N-terminal 142 amino acid sequence of human RAD54 (Golub et al., 1997) . It is, therefore, likely that a missense mutation at this Sacchi, 1987) . cDNAs were reverse transcribed, and nested PCR was performed (Sugimoto et al., 1991) . The RAD54 cDNA was divided into three segments to generate ®rst PCR products suitable for the second PCR. The N-terminal one third of the cDNA was ampli®ed with the ®rst PCR primers N15 (5'-TAGGCCCAGGATGAGGAGGA-3') and N18 (5'-AGGTTG-GATCCTC-CCTCCGA-3'). The region ampli®ed by N15 and N18 was divided into three segments for the second PCR. The ®rst segment was ampli®ed with N23 (5'-ATGAGGAG-GAGCTTGGCT-3') and N27 (5'-CTCCTTGTCAAGCTTCAG-3'). The second segment was ampli®ed with N43 (5'-GCAGT-CAGCATGAAGCAT-3') and N46 (5'-ACTGGTGACA-CACTCCCA-3'). The third segment was ampli®ed with N45 (5'-AGAGGGAGTGAAATTCC-3') and N18. The central region was generated with the ®rst PCR primers N45 and N8 (5'-CTCCTCTTCCACACACTT-3'). This region was divided into four segments for the second PCR. The ®rst segment was ampli®ed with N5 (5'-ATGAGGTTGGGAAATGGC-3') and N47 (5'-GAGGACTCCAACATGAAG-3'). The second segment was ampli®ed with N41 (5'-ATCCAACCTCTGGCCAT-3') and N42 (5'-ATTCAT-GGGCAGTCCCT-3'). The third segment was ampli®ed with N50 (5'-TGGACAGCTTGAACACCA-3') and N49 (5'-CAATTCTT-CTGCCGGTT-3'). The fourth segment was ampli®ed with N19 (5'-AGGGACTGCCCATGAAT-3') and N8. The C-terminal one-third was ampli®ed with the ®rst PCR primers N33 (5'-GGAGGACTTCTGATATCC-3') and N14 (5'-CAGACCAG-CTGGTTATCA-3'). Then this region was divided into three segments for the second PCR. The ®rst segment was ampli®ed with N31 (5'-TTGCTTGAGGGCAAGATG-3') and N36 (5'-TACAACCTTGGCTCGCTT-3'). The second segment was ampli®ed with N37 (5'-GGATGGCACGATGTCCATT-3') and N40 (5'-CTTCTTGTGGCTGAC-3'). The third segment was ampli®ed with N39 (5'-TCTGGCGAGATGGTCAA-3') and N24 (5'-TGGTTATCAGCGGAGGC-3'). Thirty cycles of amplification were performed with Taq polymerase (Amersham), each cycle consisting of 1 min at 948C, 1 min at 508C and 1 min at 728C. The PCR reactions were done in duplicates to exclude false positives possibly generated by Taq polymerase errors. Using ®rst PCR products, the second round of PCR was performed with primers that were radiolabeled with T4 polynucleotide kinase and g-32 P-ATP. Radiolabeled PCR products were denatured by boiling in 90% formamide and electrophoresed at 158C on nondenaturing 5% polyacrylamide gel containing 10% glycerol, which was subjected to autoradiography. PCR products were directly sequenced in both directions using Sequenase PCR product sequencing kit (Amersham) region aects the interaction between RAD54 and RAD51. Val at codon 444 is conserved from chicken to human RAD54 throughout evolution (Figure 2b ). ERCC6 contains several motifs of functional importance including an acidic part, nuclear location signals and casein kinase II phosphorylation sites outside helicase domains (Troelstra et al., 1992) . These motifs are not well conserved in members of the SNF2/SWI2 superfamily. By analogy with the functional motifs outside helicase domains in ERCC6, it is possible that conserved regions outside helicase domains is important for RAD54 functions.
RAD54 maps to human chromosome 1p32 where loss of heterozygosity is observed in breast cancer (Rasio et al., 1997) . It is possible that RAD54 is the breast cancer susceptibility gene mapped to 1p32. However, the low mutation frequency of RAD54 in breast cancer indicates that another tumor suppressor mapped to this region is frequently mutated in breast cancer.
Besides such mutations, RT ± PCR demonstrated an aberrant transcript in a breast tumor Br2, an invasive ductal carcinoma from a 65-year-old female patient (Figure 3a ). Br2 carried a 34 bp insertion at codon 496 upstream of helicase motif IV, resulting in a frameshift (Figure 3b ). Since the site of the 34 bp insertion was the boundary between exons 13 and 14 (Rasio et al., 1997) , we isolated the corresponding genomic clone and found that the insertion was derived from intron 13 (Figure 3c ). It is possible that either a mutation at the splice acceptor site or an intronic mutation which creates a novel splice acceptor site is responsible for the aberrant transcript. Sequence analysis of the genomic fragments revealed no mutation around the splice acceptor site in the tumor and the presence of an alternative splice acceptor site in the wild-type allele, which was used as the sole splice acceptor site in Br2. It is still possible that a mutation at some distance from the splice acceptor site is leading to the abnormal splicing event. Even if the altered transcript is not caused by a mutation in RAD54 itself, the resulting transcript could still lead to a truncated, presumably non-functional protein; adding weight to the evidence that alterations of RAD54 function can lead to cancer. The same aberrant transcript was identi®ed in a breast tumor Br1, an invasive ductal carcinoma from a 73-year-old male patient. In contrast with Br2 in which no wild-type transcript was detected, Br1 expressed the wild-type mRNA. This is the ®rst genetic evidence that alterations of a gene directly involved in repair processes involving homologous recombination can contribute to carcinogenesis. RAD54 was originally identi®ed as a gene responsible for recombinational repair in S. cerevisiae (Emery et al., 1991) . Null RAD54 cells in higher eukaryotes show reduced X-ray resistance and homologous recombination frequencies, suggesting that the RAD54 function is conserved throughout evolution (Essers et al., 1997; Bezzubova et al., 1997) . Furthermore, human RAD54 has ATPase activity Figure 2 The conservation of the amino acids that were mutated in primary cancer. (a) The amino acid sequences of helicase domain III in the SNF2/SWI2 superfamily (Eisen et al., 1995) . Identical amino acids conserved in the SNF2/SWI2 family are shown in bold. Glycine at codon 325 of RAD54, which was mutated in Br7, is indicated by an asterisk. SNF2 is a transcriptional regulator isolated from S. cerevisiae (Laurent et al., 1991) . BRM is a regulator of Drosophila homeotic genes, brahma (Tamkun et al., 1992) . LDS is the Drosophila lodestar protein whose mutations lead to excessive chromosome breakage and tangling (Girdham and Glover, 1991) . ERCC6 is a human repair protein whose mutations lead to Cockayne's syndrome (Troelstra et al., 1992) . RAD16 is a repair protein isolated from S. cerevisiae (Bang et al., 1992) . hRAD54 represents human RAD54 (Kanaar et al., 1996) . (b) The amino acid sequences of the region between helicase domains III and IV. Val at codon 444 of hRAD54 indicated by an asterisk is conserved from chicken to human. RAD54 of chicken and mouse are designated as GdRAD54 (Bezzubova et al., 1997) and mRAD54 (Kanaar et al., 1996) , respectively The sequence of exon-intron junctions from exon 13 to exon 14. Putative splice acceptor sites are indicated by asterisks. Br2 used the splice acceptor site not used in normal tissue, resulting in an addition of the 34 bp cDNA between exon 13 and exon 14. A genomic fragment corresponding to the aberrant transcript was ampli®ed with primers N9 (5'-AAGTGTGTGGAAGAGGAG-3') and N34 (5'-ACTTTGT-CACTGCTACGG-3') and cloned into the pCR2.1 vector (Invitrogen). Sequencing was performed using Sequenase DNA sequencing kit (Amersham) that is absolutely dependent on double-stranded DNA (Swagemakers et al., 1998) . Since biochemical studies indicate that yeast and human SWI/SNF complexes use the energy of ATP hydrolysis to disrupt nucleosome structure, it is suggested that RAD54 may play a role in chromatin remodeling (Peterson and Tamkun, 1995) . Given that the RAD54 function is altered, we might expect that genetic instability is induced, which consequently leads to tumor formation. RAD54 is altered in a small percentage of unselected primary tumors. In this respect, RAD54 is similar to BRCA1, BRCA2 and a BRCA1-associated RING domain gene (BARD1) (Thai et al., 1998) . It is possible that other members of the RAD52 epistasis group associated with the BRCA/RAD51 complex are mutated in cancer. This might account for the low mutation frequency of proteins in the BRCA/RAD51 complex in cancer. Although alterations of RAD54 are found in a small fraction of primary tumors, these ®ndings provide new insight into genetic instability underlying carcinogenesis.
